Researchers examine cancer drug guidelines and FDA approvals
Drugs for serious or life-threatening diseases can receive expedited U.S. Food and Drug Administration (FDA) review, allowing patients to receive faster access to promising new treatments. Under the expedited review pathway ...
Jul 2, 2024
0
0